Gates Foundation renews collaboration with Beijing government and Tsinghua University on innovative therapies for infectious diseases prevalent in low- and middle-income countries

The Bill & Melinda Gates Foundation  announced a renewed collaboration with the Beijing Municipal Government and Tsinghua University to support the Global Health Drug Discovery Institute (GHDDI) in its efforts to improve health outcomes worldwide through lifesaving therapies for infectious diseases such as tuberculosis and malaria, which disproportionately affect the world’s poorest. Low- and middle-income countries (LMICs) bear 90% of the global burden of infectious diseases, but only 10% of global spending on drug research and development goes toward diseases that disproportionately affect these populations, underscoring a clear case of global health inequality. GHDDI, a nonprofit institution established in 2016 as China’s first public-private partnership on innovative research between the Beijing Municipal Government, Tsinghua University, and the Gates Foundation, aims to address this disparity in research priorities. Over the next five years, the Gates Foundation will provide US$50 million to GHDDI, which will be matched by the Beijing Municipal Government, in order...